Best Researcher Award
Huan Liu — Jining Medical University, China
Huan Liu is an academic researcher affiliated with Jining Medical University whose documented scholarly activity connects molecular medicine, cancer biology, biomedical chemistry, and translational research. His publication record includes investigations of tumor-associated signaling, metabolic regulation, molecular mechanisms, diagnostic considerations, and therapeutic approaches. The available bibliographic record indicates collaborative contributions across clinically oriented and laboratory-based research. Supplied bibliometric information identifies five documents, 245 citations, and an h-index of five, providing a quantitative basis for this academic recognition profile. The article summarizes documented research themes and scholarly indicators in a neutral manner.
Abstract
Huan Liu is a researcher affiliated with Jining Medical University whose scholarly work connects chemistry, molecular biology, oncology, and translational biomedical research. His publication record includes studies of tumor signaling, metabolic enzymes, molecular mechanisms, and therapeutic approaches. Available bibliographic evidence identifies contributions involving colorectal cancer proliferation, cancer metabolism, immune regulation, and targeted photodynamic therapy. His research profile is interdisciplinary, combining experimental biology with clinically relevant disease questions and molecular targets. Citation and author metrics supplied for this article indicate an emerging publication record with measurable scholarly visibility. The Best Researcher Award profile recognizes this research activity within an academic context. [5]
Keywords
TIFA; PRAS40; RSK; colorectal cancer; CHDH; IL17RB; CREB1; lactate dehydrogenase A; breast cancer; cancer metabolism; molecular signaling; photodynamic therapy; albumin-binding agent; targeted tumour therapy.
Introduction
Huan Liu is affiliated with Jining Medical University in China and contributes to research spanning molecular medicine, cancer biology, and biomedical research. His documented publications address signaling pathways, metabolic regulation, tumor progression, and therapeutic strategies. These themes place his work within translational research, linking molecular mechanisms with relevant disease questions. [2] [3]
Research Profile
Huan Liu’s profile reflects an interdisciplinary orientation centered on molecular mechanisms of disease and clinical relevance. Documented studies examine TIFA signaling in colorectal cancer, CHDH biology in breast cancer, lactate dehydrogenase A, and regulation. His work also includes photodynamic agent development, illustrating connections among chemistry, molecular imaging, and therapeutic research. [2] [4] [5]
Research Contributions
Huan Liu has contributed to studies investigating cancer-associated signaling, metabolic enzymes, and therapeutic mechanisms. His authorship in research on TIFA links molecular signaling with colorectal cancer proliferation, while work on CHDH examines metabolic and signaling relationships in breast cancer. Additional contributions address lactate dehydrogenase A and photodynamic therapy, broadening translational relevance. [2] [4]
Publications
Huan Liu’s documented publications include research on TIFA-dependent colorectal cancer proliferation, CHDH-associated cancer mechanisms, lactate dehydrogenase A in breast cancer diagnosis and treatment, and albumin-binding photodynamic agents for targeted tumour therapy. These studies connect molecular signaling, cancer metabolism, diagnostic investigation, and therapeutic development across collaborative clinical and laboratory research settings. [2] [3]
Research Impact
Huan Liu’s research impact can be considered through supplied Scopus metrics of five documents, 245 citations, and an h-index of five. These indicators suggest that indexed publications have achieved scholarly attention relative to the stated publication count. His research also contributes to molecular science addressing cancer diagnosis, progression, metabolism, and treatment. [1]
Award Suitability
Huan Liu’s documented research activity provides a basis for consideration under a recognition framework focused on publication quality, citation visibility, interdisciplinary relevance, and biomedical contribution. The supplied indicators support scholarly reach, while themes demonstrate engagement with cancer biology, molecular mechanisms, metabolic regulation, and therapy development. Final decisions should remain committee-based and evidence-led. [1]
Conclusion
Huan Liu’s profile combines molecular cancer research, biomedical chemistry, and translational investigation within Jining Medical University. His documented publications address cancer signaling, metabolism, diagnostic mechanisms, and therapeutic technologies through collaborative research. The supplied citation metrics indicate visibility for a five-document record. This article provides a neutral summary for academic recognition.[4]
External Links
References
- Elsevier. (n.d.). Scopus author details: Huan Liu, Author ID 57222100209. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57222100209
- Shen, W., Du, W., Li, Y., Huang, Y., Jiang, X., Yang, C., Tang, J., Liu, H., Luo, N., Zhang, X., & Zhang, Z. (2022). TIFA promotes colorectal cancer cell proliferation in an RSK- and PRAS40-dependent manner. Cancer Science, 113(9), 3018–3031. https://doi.org/10.1111/cas.15432
- Li, Y., Shen, X., Yang, X., Lian, F., Li, Y., Li, J., Huang, Y., Shen, W., & Liu, H. (2023). CHDH, a key mitochondrial enzyme, plays a diagnostic role in metabolic disorders diseases and tumor progression. Frontiers in Genetics, 14. https://doi.org/10.3389/fgene.2023.1240650
- Li, Y., Liu, Y., Yang, X., et al. (2025). CHDH Promotes Breast Cancer Metastasis Relying on IL17RB/CREB1 Signalling Activation. Journal of Cellular and Molecular Medicine, 29, e70792. https://doi.org/10.1111/jcmm.70792
- Liu, H., Yu, C., Lyu, M., Lyu, S., Hu, L. N., Xiao, E., & Xu, P. (2023). Novel albumin-binding photodynamic agent EB-Ppa for targeted fluorescent imaging guided tumour photodynamic therapy. RSC Advances, 13(6), 3534–3540. https://doi.org/10.1039/d2ra07380c
